Max Lataillade

基本信息

浏览量：13

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 100 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 1 Study of VH4524184 (VH-184), a New Third-Generation Integrase Strand Transfer Inhibitor with a Unique Resistance Profile

L. Rogg,M. Underwood, N. Hanan, J. R. Castillo-Mancilla,L. Kahl, F. Halliday, J. L. Jeffrey, S. Byrne, T. Onodera, J. Horton,M. Lataillade,M. Gartland

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2024): 16-17

引用0浏览0引用

Augmentation Des Lymphocytes T CD4+ Et Réduction Générale Des Biomarqueurs Inflammatoires Indépendamment Du Taux De Lymphocytes T CD4+ À L'inclusion Pendant 240 Semaines De Traitement Par Fostemsavir (FTR) + Traitement De Fond Optimisé (TFO) Dans L'étude BRIGHTE

G. Pialoux, A. Dyson, J. Castillo-Mancilla,F. Du, B. Li,M. Lataillade,A. Tenorio,A. Clark,M. Prakash,D. Neau

Médecine et Maladies Infectieuses Formationno. 2 (2024): S142-S142

引用0浏览0引用

Modèles Multivariés Étendus Pour Identifier Les Facteurs Prédictifs De La Réponse Virologique Au Fostemsavir Dans L'étude BRIGHTE

A. Marcelin, B. Li,F. Du,M. Krystal,A. Clark,M. Lataillade,A. Tenorio, J. Castillo-Mancilla,M. Gartland, X. Wang

Médecine et Maladies Infectieuses Formationno. 2 (2024): S141-S142

引用0浏览0引用

Efficacy and Safety of the HIV-1 Maturation Inhibitor GSK3640254+dolutegravir As a 2-Drug Regimen in Treatment-Naive Adults: 24-Week Results from the Phase IIb DYNAMIC Study

S. R. Joshi,M. Masia, E. Mitha,A. Castagna,E. Cordova,M. Ramgopal, A. Gaudion, S. Karthika,J. Oyee, V. Bainbridge,B. Wynne,M. Lataillade

HIV MEDICINE (2023): 210-211

引用0浏览0引用

Sustained Improvements in Biomarkers Observed with Fostemsavir in Heavily Treatment-Experienced Adults with Multidrugresistant HIV-1 from the Phase 3 BRIGHTE Study Through Week 240

A. Castagna,C. Mussini,J. M. Llibre,A. Antinori,M. Prakash,A. Pierce, J. R. Castillo-Mancilla,A. Tenorio, M. Wang,F. Du,A. Clark,M. Lataillade

HIV MEDICINE（2023）

引用0浏览0引用

Effects of the HIV‐1 Maturation Inhibitor GSK3640254 on QT Interval in Healthy Participants

Ying Zhang,Mark Bush,Parto Yazdani,Joyce Zhan,Bo Wen,Veronica Bainbridge,Brian R. Wynne,Samit Joshi,Max Lataillade

Pharmacology Research &amp Perspectives（2023）

引用0浏览0WOS引用

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1

Judith A. Aberg,Bronagh Shepherd,Marcia Wang,Jose V. Madruga,Fernando Mendo Urbina,Christine Katlama,Shannon Schrader,Joseph J. Eron,Princy N. Kumar,Eduardo Sprinz,Margaret Gartland,Shiven Chabria,Andrew Clark,Amy Pierce,Max Lataillade,Allan R. Tenorio

Infectious Diseases and Therapyno. 9 (2023): 2321-2335

引用6浏览0WOS引用

Early and durable reductions in soluble CD14 concentrations among treatmentexperienced persons with HIV-1 through 96 weeks of fostemsavir treatment in a Phase 2b clinical trial

E. R. Wonderlich,M. Prakash,A. Clark, J. R. Castillo-Mancilla, N. Ray, M. Wang,M. Lataillade,A. Tenorio

HIV MEDICINE（2023）

引用0浏览0引用

Efficacy and Safety of the HIV-1 Maturation Inhibitor GSK3640254+2 NRTIs in Treatment-Naive Adults: 24-Week Results from the Phase IIb, Dose-Range Finding DOMINO Study

S. R. Joshi,E. Cordova, E. Mitha,A. Castagna,M. Ramgopal,J. M. Llibre,A. Potthoff, O. E. Chernova, S. A. Nunez,C. Man, J. L. Jeffrey, C. Fishman,J. Oyee, A. Joshi, Y. Zhang, V. Bainbridge,B. Wynne,M. Lataillade

HIV MEDICINE (2023): 208-209

引用0浏览0引用

Open‐label, Drug–drug Interaction Study Between the HIV‐1 Maturation Inhibitor GSK3640254 and a Metabolic Probe Cocktail in Healthy Participants

Ying Zhang,Mark Johnson,Samit Joshi,Parto Yazdani,Joyce Zhan,Bo Wen,Veronica Bainbridge,Martin Gartland,Max Lataillade

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

其他

论文共 100 篇作者统计合作学者相似作者